The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults

计划入组 98 人 · 首次发布于 2019 年 1 月 10 日

Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease

计划入组 100 人 · 首次发布于 2023 年 8 月 8 日

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

计划入组 484 人 · 首次发布于 2011 年 1 月 7 日

Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine(Menveo)

Trivalent Invasive Salmonella Disease Vaccine(University of Maryland)

CVD-1000

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Sanofi's MenQuadfi Wins EU Approval for Infants from Six Weeks of Age Against Invasive Meningococcal Disease

GSK's Meningococcal Group B Vaccine Approved in the Philippines

GSK's Single-Vial, Fully Liquid Menveo Receives Positive CHMP Opinion for Meningococcal Disease Prevention